A Phase 1, Double Blind, Randomized, Placebo Controlled, Parallel Design Pharmacokinetic Drug Interaction Study of ACH-0143102 and ACH-0142684 in Healthy Volunteers.

Trial Profile

A Phase 1, Double Blind, Randomized, Placebo Controlled, Parallel Design Pharmacokinetic Drug Interaction Study of ACH-0143102 and ACH-0142684 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Deldeprevir (Primary) ; Odalasvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Achillion Pharmaceuticals
  • Most Recent Events

    • 17 Jul 2014 According to the Australian New Zealand Clinical Trials Registry record, status changed from not yet recruiting to completed.
    • 06 Mar 2014 As per Australian New Zealand Clinical Trials Registry record planned initiation date changed from 1 Mar 2014 to 3 Feb 2014.
    • 06 Mar 2014 As per Australian New Zealand Clinical Trials Registry record trials status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top